Baxter (BAX) Misses Q4 EPS by 6c, Guidance Misses

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/8/2026

1. SBUX
2. LEVI
3. SPCX
4. NVDA
5. USO
6. STZ
7. SPY
8. GOOGL
9. APLD
10. ORCL

Go back to Baxter (BAX) Misses Q4 EPS by 6c, Guidance Misses

Baxter Reports Fourth-Quarter and Full-Year 2022 Results

February 9, 2023 7:15 AM EST

Fourth-quarter sales of $3.9 billion increased 11% on a reported basis, 17% on a constant currency basis and 2% on an operational basis1 Fourth-quarter U.S. GAAP diluted earnings per share (EPS) of $0.36 and adjusted diluted EPS of $0.88 Full-year sales of $15.1 billion increased 18% on a reported basis, 23% on a constant currency basis and 2% on an operational basis Full-year U.S. GAAP diluted EPS (loss) of ($4.83) and adjusted diluted EPS of $3.50 Company provides update on previously announced actions to improve operational efficiency through streamlined operating model while positioning for proposed spinoff of Renal Care and Acute... More